Sponsor:
Victor Wang
Code:
NCT06564233
Conditions
Hematopoietic Stem Cell Transplantation
Cancer
Eligibility Criteria
Sex: All
Age: 19+
Healthy Volunteers: Not accepted
Interventions
care.coach Avatar™
Brief summary:
Conditions
Hematopoietic Stem Cell Transplantation
Cancer
Study ID
NCT06564233
Start date
Oct 21, 2024
Status verified date
Mar, 2026
Completion date
Nov 29, 2026
Anticipated
Primary completion date
Sep 20, 2026
Anticipated
Eligibility Criteria
Sex: All
Age: 19+
Healthy Volunteers: Not accepted
Enrollment
90 participants
Anticipated
Allocation
Randomized
Intervention Model
Parallel Assignment
Primary purpose
Supportive Care
Arms
experimental: care.coach Avatar™
no intervention: Usual Supportive Care
Interventions
care.coach Avatar™
Primary outcome measure
Central contacts
Locations
Dana-Farber Cancer Institute
Recruiting
Boston, Massachusetts, United States, 02215
Contacts
Amar H Kelkar, MD
amarh_kelkar@dfci.harvard.eduPrincipal Investigator:
Gregory A Abel, MD
Sponsor
Victor Wang
Last update posted
Mar 6, 2026
Last verified
Mar, 2026
Keywords
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Victor Wang on 2026-03-06.